This compound is primarily utilized in pharmaceutical research and development as an intermediate in the synthesis of biologically active molecules. It is particularly valuable in the design and production of compounds targeting central nervous system disorders, including potential treatments for anxiety, depression, and neurodegenerative diseases. Its structural features, such as the piperazine and piperidine moieties, make it a versatile building block for creating drug candidates with enhanced binding affinity and selectivity. Additionally, it is employed in the development of protease inhibitors and other therapeutic agents, contributing to advancements in medicinal chemistry.